PWeR Blog
Sign up today for the latest PWeR development announcement!
Breaking News: FTX Cryptocurrency Exchange Implodes In Less Than 1O Days
Breaking News: FTX Cryptocurrency Exchange implodes in less than 1O days, wiping out 100s of billions of dollars for an estimated 1 million stakeholders. We have just witnessed the collapse of FTX[1], an international Cryptocurrency exchange, that until recently, was run by Sam Bankman-Fried (SBF) from a base in the Bahama’s. We have seen the headlines everywhere[2] reminiscent of the implosion of Theranos. “FTX” and the news is overwhelming. In short, regulators and governments from all over the world are investigating over 100 companies affiliated with FTX for criminal violations. This […]
READ MORE
Breaking News: CMS Published Its Annual Payment Updates for Physicians for 2023
Breaking News: CMS has published its annual payment updates for physicians for 2023, and once again, reimbursements are cut by 4.5%. On November 1, 2022, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that includes updates and policy changes for Medicare payments under the Physician Fee Schedule (PFS), and other Medicare Part B and Part D issues, in particular relating to drug cost, effective on or after January 1, 2023[1]. As we have noted in previous blogs, the days of Fee-For-Service (FFS) are going to be […]
READ MORE
The Economics of Healthcare – Part 12
We are finally seeing some ‘Big Players’ entering the healthcare delivery of care. A few years back, when Haven Health was created by Jaime Dimon (JP Morgan), Jeff Bezos (then CEO of Amazon) and Warren Buffett (CEO of Berkshire Hathaway), we predicted it would not work. Well, three (3) years later they dissolved the company. The reason we predicted it would not work was primarily two (2) reasons. First, the healthcare industry did not need another Group Purchasing Organization or GPO. Second, their mission of “changing healthcare” was impossible, unless […]
READ MORE
The Economics of Healthcare – Part 11
In Part 10 of our blog series, The Economics of Healthcare, we left off at discussing the problems most hospitals are having post-COVID. These problems are labor and material/supply costs, items basic to their operation. Then, there is the overall billing/revenue cycle that fails to accommodate any but the most minor pricing elasticity. The changes needed to these areas will likely take years to play out. Increasing costs have been materially fueled by the overall inflation, supply chain shortages creating additional demand-push inflation with attending supply cost adjustments, reduction or […]
READ MORE
The Economics of Healthcare – Part 10
Though we have presented on a historical basis that healthcare has been recession proof, it does not mean that there are not issues in healthcare that create major problems in good times and in bad times. I have told many students and investment bankers that with healthcare comprising over 20% of the U.S. economy, there is always a part of the industry that is on fire and one that is melting down. Today, insurance companies are on fire as companies continue expanding into healthcare. As we mentioned previously, we are […]
READ MORE
The Economics of Healthcare – Part 9
On August 4, 2022, the President of United States Joseph R. Biden Jr., signed in to law the Inflation Reduction Act of 2022 (IRA)[1]. This comprehensive law covered many areas, including healthcare (our sole focus), clean energy and taxes according to The White House release[2]. Without getting political, let’s look at what is promoted by those sponsoring the new law. The following is a section The White House noted : HEALTH CARE Cutting Prescription Drug Cost Today, Americans pay two to three times what citizens of other countries pay for prescription drugs. […]
READ MORE
The Economics of Healthcare – Part 8
We’ve received some excellent feedback from our readers, and we are encouraged to hear that this series of blogs has been of value. When we re-titled the blog, The United States of Healthcare (SM), it was to point out how the number one industry in the U.S., for consistently recuring expenditures regardless of the market and Gross Domestic Products (GDP), was healthcare. Frankly, it appears that this will remain so for surely at least the next decade. The basic driver is plain and simple demographics. We have also noted in […]
READ MORE